Organization Profile

You just read:

OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer

News provided by

OncoGenex Pharmaceuticals, Inc.

Sep 27, 2012, 16:31 ET